NCT05375045 Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants
| NCT ID | NCT05375045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Euroteknika |
| Condition | Edentulous Mouth |
| Study Type | OBSERVATIONAL |
| Enrollment | 868 participants |
| Start Date | 2022-03-25 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 868 participants in total. It began in 2022-03-25 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Real-life evaluation of the safety and performance of EUROTEKNIKA dental implants
Eligibility Criteria
Inclusion Criteria: * Patient aged 18 or over * Patient who has completed bone growth * Patient informed and agreeing to participate in the study * Partially or totally edentulous patient who will be implanted with the EUROTEKNIKA dental implant (for the prospective cohort) * Patient to benefit from the placement of an implant for the creation of a single crown (for the prospective cohort) * Patient implanted with the EUROTEKNIKA dental implant before 2017 (for the retrospective cohort) * Patient having benefited from the placement of an implant for the creation of a single crown (for the retrospective cohort) Exclusion Criteria: * Pregnant or breastfeeding women (for the prospective cohort) * Patient with bone disease in the cervico-facial region * Patient refusing to participate in the study * Patient with at least one contraindication to implantation (for the prospective cohort) * Patient to benefit from the placement of an implant with immediate or early loading (for the prospective cohort) * Patient to benefit from the placement of an implant for the support of the bridge, piles, attachment (for the prospective cohort) * Patient having benefited from the placement of an implant with immediate or early loading (for the retrospective cohort) * Patient having benefited from the placement of an implant for the support of the bridge, piles, attachment (for the retrospective cohort)
Frequently Asked Questions
Who can join the NCT05375045 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Edentulous Mouth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05375045 currently recruiting?
Yes, NCT05375045 is actively recruiting participants. Visit ClinicalTrials.gov or contact Euroteknika to inquire about joining.
Where is the NCT05375045 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT05375045 clinical trial?
NCT05375045 is sponsored by Euroteknika. The trial plans to enroll 868 participants.